Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of aranidipine enteric-coated tablets versus amlodipine in mild to moderate essential hypertension
ChiCTR-TRC-11001538Phase 2Completed
- Sponsor
- Key Laboratory of Clinical Trial Research in Cardiovascular Drugs, FuWai Hospital
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aranidipine in essential hypertension (2 arms), sponsored by Key Laboratory of Clinical Trial Research in Cardiovascular Drugs, FuWai Hospital. Primary endpoint: Change from baseline in seated diastolic blood pressure at 10 weeks. Started Jun 2008; status: completed.
02
Drugs
aranidipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR-TRC-11001538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001538.